vTv Therapeutics Inc. (NASDAQ: VTVT) is a clinical-stage biopharmaceutical enterprise headquartered in High Point, North Carolina, focused on discovering and developing oral, small-molecule drug candidates. The organization specializes in creating innovative treatments targeting severe metabolic disorders, autoimmune conditions, and type 1 or type 2 diabetes. By advancing proprietary therapeutic programs through rigorous human clinical trials, the company collaborates with global healthcare networks to address significant unmet medical needs.